Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias

被引：2
|
作者：
Ball, Brian [1 ]
Arslan, Shukaib [2 ]
Koller, Paul [2 ]
Murata-Collins, Joyce [3 ]
Afkhami, Michelle [4 ,5 ]
Pillai, Raju [4 ,5 ]
Gaal, Karl [1 ]
Salhotra, Amandeep [2 ]
Al Malki, Monzr M. [2 ]
Aribi, Ahmed [2 ]
Ali, Haris [2 ]
Otoukesh, Salman [2 ]
Amanam, Idoroenyi [2 ]
Nakamura, Ryotaro [2 ]
Smith, Eileen P. [2 ]
Stewart, Forrest [1 ]
Marcucci, Guido [5 ]
Pullarkat, Vinod A. [6 ]
Aldoss, Ibrahim [2 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Hematol HCT, Duarte, CA USA
[3] City Hope Med Ctr, Duarte, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Beckman Res Inst, Gehr Family Ctr Leukemia Res,Dept Hematol Maligna, Hematol Malignancies & Stem Cell Transplantat Ins, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148670
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3430
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
    Ball, Brian J.
    Arslan, Shukaib
    Koller, Paul
    Ngo, Dat
    Afkhami, Michelle
    Salhotra, Amandeep
    Al-Malki, Monzr
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Otoukesh, Salman
    Amanam, Idoroenyi
    Pourhassan, Hoda
    Artz, Andrew
    Curtin, Peter
    Stein, Anthony
    Nakamura, Ryotaro
    Marcucci, Guido
    Smith, Eileen
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3232 - 3236
  • [2] Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
    Lopes, Bruno A.
    Poubel, Caroline Pires
    Teixeira, Cristiane Esteves
    Caye-Eude, Aurelie
    Cave, Helene
    Meyer, Claus
    Marschalek, Rolf
    Boroni, Mariana
    Emerenciano, Mariana
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor
    Cantilena, Sandra
    Alameri, Mohamed
    Che, Noelia
    Williams, Owen
    de Boer, Jasper
    CANCERS, 2024, 16 (23)
  • [4] NOVEL COMPOUNDS SYNERGIZE WITH VENETOCLAX TO TARGET KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
    Tregnago, C.
    Benetton, M.
    Da Ros, A.
    Borella, G.
    Longo, G.
    Polato, K.
    Francescato, S.
    Biffi, A.
    Pigazzi, M.
    HAEMATOLOGICA, 2022, 107 : 67 - 68
  • [5] Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
    Tregnago, Claudia
    Benetton, Maddalena
    Da Ros, Ambra
    Borella, Giulia
    Longo, Giorgia
    Polato, Katia
    Francescato, Samuela
    Biffi, Alessandra
    Pigazzi, Martina
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [6] Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
    Burmeister, Thomas
    Stroeh, Aeint-Steffen
    Kehden, Britta
    Trautmann, Heiko
    Meyer, Claus
    Marschalek, Rolf
    Larghero, Patrizia
    Schwartz, Stefan
    Steffen, Bjoern
    Spriewald, Bernd
    Heinicke, Thomas
    Jaekel, Nadja
    Westermann, Joerg
    Nachtkamp, Kathrin
    Viardot, Andreas
    Topp, Max S.
    Neumann, Martin
    Baldus, Claudia D.
    Goekbuget, Nicola
    Brueggemann, Monika
    LEUKEMIA, 2024, 38 (07) : 1600 - 1603
  • [7] Nuclear Structure of KMT2A-Rearranged Infant ALL
    Namikawa, Yui
    Muhaimin, Riski
    Tomomasa, Dan
    Nishimura, Akira
    Ishii, Eiichi
    Tomizawa, Daisuke
    Miyamura, Takako
    Isoda, Takeshi
    Takagi, Masatoshi
    CANCER SCIENCE, 2025, 116 : 563 - 563
  • [8] KMT2A-Rearranged DLBCL Refractory to Intensive Chemotherapy
    Kubota, Y.
    Sekiguchi, M.
    Watanabe, K.
    Oka, A.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    Hiwatari, M.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S185 - S186
  • [9] The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients
    Wu, Yibo
    Yuan, Xiaolin
    Lai, Xiaoyu
    Liu, Lizhen
    Shi, Jimin
    Zheng, Weiyan
    Yu, Jian
    Zhao, Yanmin
    Sun, Jie
    Ye, Xiujin
    Cai, Zhen
    Huang, He
    Pei, Shanshan
    Luo, Yi
    BLOOD, 2024, 144 : 843 - 844
  • [10] Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
    Cheung, Laurence C.
    Aya-Bonilla, Carlos
    Cruickshank, Mark N.
    Chiu, Sung K.
    Kuek, Vincent
    Anderson, Denise
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Ferrari, Emanuela
    Hughes, Anastasia M.
    Ford, Jette
    Kunold, Elena
    Hesselman, Maria C.
    Post, Frederik
    Faulk, Kelly E.
    Breese, Erin H.
    Guest, Erin M.
    Brown, Patrick A.
    Loh, Mignon L.
    Lock, Richard B.
    Kees, Ursula R.
    Jafari, Rozbeh
    Malinge, Sebastien
    Kotecha, Rishi S.
    LEUKEMIA, 2023, 37 (01) : 61 - 71
12345